Active, not recruitingPhase 3NCT02261415

The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial

Studying Pediatric hepatocellular carcinoma

Last synced from ClinicalTrials.gov May 18, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sunnybrook Health Sciences Centre
Principal Investigator: Paul Karanicolas, MD PhD, MD
Sunnybrook Health Sciences Centre
Intervention: Tranexamic acid (TXA)(drug)
Enrollment: 1386 enrolled
Eligibility: 18 years · All sexes
Timeline: 2014 – 2027

Study locations (11)

Mayo Clinic, Rochester, Minnesota, United States
Foothills Hospital, Calgary, Alberta, Canada
Kelowna General Hospital, Kelowna, British Colombia, Canada
Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
Hamilton Health Sciences, Hamilton, Ontario, Canada
Kingston General Health Research Institute, Kingston, Ontario, Canada
London Health Sciences Centre, London, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
University Health Network, Toronto, Ontario, Canada
St. Joseph's Health Centre, Toronto, Ontario, Canada
McGill University Health Centre, Montreal, Quebec, Canada

Collaborators

HepatoPancreaticoBiliary (HPB) Concept Team

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02261415 on ClinicalTrials.gov

Other trials for Pediatric hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Pediatric hepatocellular carcinoma →

← Back to all trials